logo-loader

Progenics Pharmaceuticals, Inc.

Receive alerts
Market:
NASDAQ
Market Cap:
$442.48 m
Price
5.12 USD
Change
2.61%
52 weeks high
6.31
52 weeks low
3.43

In brief

Progenics Pharmaceuticals, Inc., of Tarrytown, NY, is a biopharmaceutical company with programs in gastroenterology, oncology and virology focused on innovative therapeutics for patients with debilitating conditions and life-threatening diseases.